|
|
 Blood Information - December 3, 2008
| A group of scientists at Johns Hopkins have figured out a non-invasive way to lower appetite by preventing the body from manufacturing the "hunger hormone" thus resulting in weight loss. This discovery holds utmost importance as it could lead to a potential solution for people who struggle with obesity. Dr. Aravind Arepally of the John Hopkins University School of Medicine created this new procedure known as gastric artery chemical embolizatioin, or GACE | | Simple leg pain can be a sign of a dangerous blood clot known as a deep vein thrombosis (DVT), which if left untreated can turn fatal by making its way up to the lungs, where it goes by the name pulmonary embolism, or PE. Deep-vein thrombosis or DVT is caused by sitting rigidly for too long, which can cause a blood clot to form in a deep vein, usually in the calf, thigh or groin. In a bid to increase awareness of the condition, the government has launched a campaign to get patients and doctors to recognize the potential emergency | | Regular brushing of teeth can reduce your chances of developing heart disease, says a new study. Researchers from the University of Bristol in Britain say that failing to scrub one's teeth can result in the formation of up to 700 different bacteria in the human mouth that in turn can trigger heart disease | | New research on Alzheimer's disease offers hope for at-risk Americans and suggests there could be changes in the way the disease is treated or that it might someday be possible to prevent it, researchers at Columbia University Medical Center say. That's important news in a nation where an estimated 5.2 million Americans already have the disease and experts warn that it could affect one out of eight Baby Boomers, the generation of people born from 1946 to 1964 | | Amylin Pharmaceuticals Inc.'s controversial Byetta diabetes treatment, produced better results in diabetic patients than Merck & Co.'s Januvia, according to data released by Amylin at a medical conference. Byetta's new version, which is co-marketed with Eli Lilly & Co. requires just one injection a week instead of two shots a day. It also worked better than Januvia in tests that measured blood-sugar levels after meals in 61 patients who tried each drug for two weeks. Januvia is a once-daily pill | |
|
|